Most of what we know about BPC-157 is from animal studies, which dont always translate to how humans respond
Neuroscience 53 : 695703 Tempesta E, Janiri L, Pirrongelli C
Cardiovascular Risk Mitigation: Used to reduce the risk of major adverse cardiovascular events (such as cardiovascular death, non-fatal heart attack, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight
It is provided for laboratory research by qualified professionals under controlled protocols
[2] A prescriber will decide whether treatment is suitable after reviewing your BMI, medical history, current medicines, previous treatments and consultation answers
This may help you sleep through the initial side effects, like drowsiness or dizziness, while your body adjusts to the medication